Identification of P-Rex1 in the Regulation of Liver Cancer Cell Proliferation and Migration via HGF/c-Met/Akt Pathway

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.2126225651787
   PubMed Web of Science ®Google Scholar
• Eggert T, Greten TF. Current standard and future perspectives in non-surgical therapy for hepatocellular carcinoma. Digestion. 2017;96(1):1–4. doi:10.1159/00046428228605745
   PubMed Web of Science ®Google Scholar
• Liang Q, Shen X, Sun G. Precision medicine: update on diagnosis and therapeutic strategies of hepatocellular carcinoma. Curr Med Chem. 2018;25(17):1999–2008. doi:10.2174/092986732566618011710153229345573
   PubMed Web of Science ®Google Scholar
• Birchmeier C, Birchmeier W, Gherardi E, Vande Woude GF. Met, metastasis, motility and more. Nat Rev Mol Cell Biol. 2003;4(12):915–925. doi:10.1038/nrm126114685170
   PubMed Web of Science ®Google Scholar
• Trusolino L, Bertotti A, Comoglio PM. MET signalling: principles and functions in development, organ regeneration and cancer. Nat Rev Mol Cell Biol. 2010;11(12):834–848. doi:10.1038/nrm301221102609
   PubMed Web of Science ®Google Scholar
• Garcia-Vilas JA, Medina MA. Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications. World J Gastroenterol. 2018;24(33):3695–3708. doi:10.3748/wjg.v24.i33.369530197476
   PubMed Web of Science ®Google Scholar
• Hung TH, Li YH, Tseng CP, et al. Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines. Cancer Gene Ther. 2015;22(5):262–270. doi:10.1038/cgt.2015.1525908454
   PubMed Web of Science ®Google Scholar
• Bouattour M, Raymond E, Qin S, et al. Recent developments of c-Met as a therapeutic target in hepatocellular carcinoma. Hepatology (Baltimore, Md). 2018;67(3):1132–1149. doi:10.1002/hep.29496
   PubMed Web of Science ®Google Scholar
• Xiang QF, Zhan MX, Li Y, et al. Activation of MET promotes resistance to sorafenib in hepatocellular carcinoma cells via the AKT/ERK1/2-EGR1 pathway. Artif Cells Nanomed Biotechnol. 2019;47(1):83–89. doi:10.1080/21691401.2018.154319530663411
   PubMed Web of Science ®Google Scholar
• Schmidt A. Guanine nucleotide exchange factors for Rho GTPases: turning on the switch. Genes Dev. 2002;16(13):1587–1609. doi:10.1101/gad.100330212101119
   PubMed Web of Science ®Google Scholar
• Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays. 2007;29(4):356–370. doi:10.1002/bies.2055817373658
   PubMed Web of Science ®Google Scholar
• Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol. 2008;9(9):690–701. doi:10.1038/nrm247618719708
   PubMed Web of Science ®Google Scholar
• Fernandez-Zapico ME, Gonzalez-Paz NC, Weiss E, et al. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis. Cancer Cell. 2005;7(1):39–49. doi:10.1016/j.ccr.2004.11.02415652748
   PubMed Web of Science ®Google Scholar
• Minard ME, Kim LS, Price JE, Gallick GE. The role of the guanine nucleotide exchange factor Tiam1 in cellular migration, invasion, adhesion and tumor progression. Breast Cancer Res Treat. 2004;84(1):21–32. doi:10.1023/B:BREA.0000018421.31632.e614999151
   PubMed Web of Science ®Google Scholar
• Murray DW, Didier S, Chan A, et al. Guanine nucleotide exchange factor Dock7 mediates HGF-induced glioblastoma cell invasion via Rac activation. Br J Cancer. 2014;110(5):1307–1315. doi:10.1038/bjc.2014.3924518591
   PubMed Web of Science ®Google Scholar
• Welch HC, Coadwell WJ, Ellson CD, et al. P-Rex1, a PtdIns(3,4,5)P3- and Gbetagamma-regulated guanine-nucleotide exchange factor for Rac. Cell. 2002;108(6):809–821. doi:10.1016/S0092-8674(02)00663-311955434
   PubMed Web of Science ®Google Scholar
• Srijakotre N, Man J, Ooms LM, Lucato CM, Ellisdon AM, Mitchell CA. P-Rex1 and P-Rex2 RacGEFs and cancer. Biochem Soc Trans. 2017;45(4):963–977. doi:10.1042/BST2016026928710285
   PubMedGoogle Scholar
• Lindsay CR, Lawn S, Campbell AD, et al. P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun. 2011;2:555. doi:10.1038/ncomms156022109529
   PubMed Web of Science ®Google Scholar
• Barrio-Real L, Kazanietz MG, Rho GE. Fs and cancer: linking gene expression and metastatic dissemination. Sci Signal. 2012;5(244):pe43. doi:10.1126/scisignal.200354323033535
   PubMed Web of Science ®Google Scholar
• Barrio-Real L, Lopez-Haber C, Casado-Medrano V, et al. P-Rex1 is dispensable for Erk activation and mitogenesis in breast cancer. Oncotarget. 2018;9(47):28612–28624. doi:10.18632/oncotarget.2558429983884
   PubMedGoogle Scholar
• Pantarelli C, Welch HCE. Rac-GTPases and Rac-GEFs in neutrophil adhesion, migration and recruitment. Eur J Clin Invest. 2018;48(Suppl 2):e12939. doi:10.1111/eci.1293929682742
   PubMedGoogle Scholar
• Huang Y, Xie Y, Jiang H, et al. Upregulated P-Rex1 exacerbates human airway smooth muscle hyperplasia in asthma. J Allergy Clin Immunol. 2019;143(2):778–781 e775. doi:10.1016/j.jaci.2018.09.02030312708
   PubMed Web of Science ®Google Scholar
• Naikawadi RP, Cheng N, Vogel SM, et al. A critical role for phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac exchanger 1 in endothelial junction disruption and vascular hyperpermeability. Circ Res. 2012;111(12):1517–1527. doi:10.1161/CIRCRESAHA.112.27307822965143
   PubMed Web of Science ®Google Scholar
• Liang Q, Cheng N, Zhang G, et al. Identification of P-Rex1 as an anti-inflammatory and anti-fibrogenic target for pulmonary fibrosis. Sci Rep. 2016;6:25785. doi:10.1038/srep2578527173636
   PubMed Web of Science ®Google Scholar
• Liu HJ, Ooms LM, Srijakotre N, et al. PtdIns(3,4,5)P3-dependent Rac Exchanger 1 (PREX1) Rac-guanine nucleotide exchange factor (GEF) activity promotes breast cancer cell proliferation and tumor growth via activation of extracellular signal-regulated Kinase 1/2 (ERK1/2) Signaling. J Biol Chem. 2016;291(33):17258–17270. doi:10.1074/jbc.M116.74340127358402
   PubMed Web of Science ®Google Scholar
• Sosa MS, Lopez-Haber C, Yang C, et al. Identification of the Rac-GEF P-Rex1 as an essential mediator of ErbB signaling in breast cancer. Mol Cell. 2010;40(6):877–892. doi:10.1016/j.molcel.2010.11.02921172654
   PubMed Web of Science ®Google Scholar
• Ye RD. The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases. Pharmacol Res. 2020;153:104676. doi:10.1016/j.phrs.2020.10467632006571
   PubMed Web of Science ®Google Scholar
• Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. 2009;9(6):400–414.19440234
   PubMed Web of Science ®Google Scholar
• Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A. The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell. 1992;70(3):401–410. doi:10.1016/0092-8674(92)90164-81643658
   PubMed Web of Science ®Google Scholar
• Menard L, Parker PJ, Kermorgant S. Receptor tyrosine kinase c-Met controls the cytoskeleton from different endosomes via different pathways. Nat Commun. 2014;5:3907. doi:10.1038/ncomms490724835487
   PubMed Web of Science ®Google Scholar
• Welch HC. Regulation and function of P-Rex family Rac-GEFs. Small GTPases. 2015;6(2):49–70. doi:10.4161/21541248.2014.97377025961466
   PubMedGoogle Scholar
• He S, Lin J, Yu S, Sun S. Upregulation of PREX2 promotes the proliferation and migration of hepatocellular carcinoma cells via PTEN-AKT signaling. Oncol Lett. 2016;11(3):2223–2228. doi:10.3892/ol.2016.416426998152
   PubMed Web of Science ®Google Scholar
• Cervantes-Villagrana RD, Adame-Garcia SR, Garcia-Jimenez I, et al. Gbetagamma signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Galphaq and Galpha13 proteins. The. J Biologica Chem. 2019;294(2):531–546. doi:10.1074/jbc.RA118.006254
   PubMed Web of Science ®Google Scholar
• Campbell AD, Lawn S, McGarry LC, Welch HC, Ozanne BW, Norman JC. P-Rex1 cooperates with PDGFRbeta to drive cellular migration in 3D microenvironments. PLoS One. 2013;8(1):e53982. doi:10.1371/journal.pone.005398223382862
   PubMed Web of Science ®Google Scholar
• Li W, Xiong X, Abdalla A, et al. HGF-induced formation of the MET-AXL-ELMO2-DOCK180 complex promotes RAC1 activation, receptor clustering, and cancer cell migration and invasion. J Biol Chem. 2018;293(40):15397–15418. doi:10.1074/jbc.RA118.00306330108175
   PubMed Web of Science ®Google Scholar
• Yang HW, Shin MG, Lee S, et al. Cooperative activation of PI3K by Ras and Rho family small GTPases. Mol Cell. 2012;47(2):281–290. doi:10.1016/j.molcel.2012.05.00722683270
   PubMed Web of Science ®Google Scholar
• Fritsch R, de Krijger I, Fritsch K, et al. RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms. Cell. 2013;153(5):1050–1063. doi:10.1016/j.cell.2013.04.03123706742
   PubMed Web of Science ®Google Scholar
• Xiang Q, Chen W, Ren M, et al. Cabozantinib suppresses tumor growth and metastasis in hepatocellular carcinoma by a dual blockade of VEGFR2 and MET. Clin Cancer Res. 2014;20(11):2959–2970. doi:10.1158/1078-0432.CCR-13-262024700742
   PubMed Web of Science ®Google Scholar
• Liu Y, Tan J, Ou S, Chen J, Chen L. MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway. Invest New Drugs. 2019.
   Web of Science ®Google Scholar
• Luo T, Zhang SG, Zhu LF, et al. A selective c-Met and Trks inhibitor Indo5 suppresses hepatocellular carcinoma growth. J Exp Clin Cancer Res. 2019;38(1):130. doi:10.1186/s13046-019-1104-430885237
   PubMedGoogle Scholar
• Cash JN, Chandan NR, Hsu AY, et al. Discovery of small molecules that target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP3)-Dependent Rac Exchanger 1 (P-Rex1) PIP3 -Binding Site and Inhibit P-Rex1–dependent functions in neutrophils. Mol Pharmacol. 2020;97(3):226–236. doi:10.1124/mol.119.11755631900312
   PubMed Web of Science ®Google Scholar